{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T12:03:07Z","timestamp":1766318587403,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Karolinska University Hospital","award":["20110263","20110604"],"award-info":[{"award-number":["20110263","20110604"]}]},{"name":"University Hospital of Ume\u00e5","award":["VLL-582231"],"award-info":[{"award-number":["VLL-582231"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bcmd.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T23:06:07Z","timestamp":1477004767000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1"],"prefix":"10.1016","volume":"68","author":[{"given":"Fryderyk","family":"Lorenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Paw\u0142owicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Klimkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheir","family":"Beshara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Bulanda Brustad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander B.","family":"Skotnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-0463","authenticated-orcid":false,"given":"Anders","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-4127","authenticated-orcid":false,"given":"Maciej","family":"Machaczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2016.10.010_bb0005","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2011-04-308890","article-title":"How I treat Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2016.10.010_bb0010","first-page":"S12","article-title":"Gaucher disease types 1 and 3: phenotypic characterization of large populations from the ICGG Gaucher registry","volume":"90","author":"Grabowski","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.20452\/pamw.2493","article-title":"Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1","volume":"124","author":"Machaczka","year":"2014","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5603\/FHC.a2015.0003","article-title":"Atypical cytomorphology of Gaucher cells is frequently seen in bone marrow smears from untreated patients with Gaucher disease type 1","volume":"53","author":"Markuszewska-Kuczy\u0144ska","year":"2015","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10545-010-9241-0","article-title":"Gaucher disease with foamy transformed macrophages and erythrophagocytic activity","volume":"34","author":"Machaczka","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0035","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00277-014-2036-x","article-title":"Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1","volume":"93","author":"Machaczka","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00005-014-0308-8","article-title":"Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3","volume":"63","author":"Machaczka","year":"2015","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","article-title":"The clinical management of type 2 Gaucher disease","volume":"114","author":"Weiss","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s10545-009-1217-6","article-title":"Effort bruising disclosing Gaucher disease in a 55-year-old non-Jewish woman","volume":"32","author":"Machaczka","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/03009734.2011.641609","article-title":"Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution","volume":"117","author":"Machaczka","year":"2012","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0060","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2012.04.002","article-title":"Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment","volume":"49","author":"Mekinian","year":"2012","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bcmd.2014.07.007","article-title":"Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease","volume":"53","author":"Medrano-Engay","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.bcmd.2016.10.010_bb0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.achaem.2013.07.186","article-title":"Analysis of ferritinemia and serum soluble interleukin-2 receptor \u03b1 concentration in type 1 Gaucher disease","volume":"44","author":"Lorenz","year":"2013","journal-title":"Acta Haematol. Pol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0080","first-page":"2097","article-title":"Hereditary hemochromatosis \u2013 a common genetic disease","volume":"109","author":"St\u00e5l","year":"2012","journal-title":"Lakartidningen"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0085","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/265755a0","article-title":"Ferritinaemia in cancer","volume":"265","author":"Hazard","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0090","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nrmicro1046","article-title":"Iron and microbial infection","volume":"2","author":"Schaible","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1398.044","article-title":"Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases","volume":"1109","author":"Orbach","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0100","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/eji.200939889","article-title":"Differential regulation of iron homeostasis during human macrophage polarized activation","volume":"40","author":"Recalcati","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00277-008-0441-8","article-title":"Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature","volume":"87","author":"de Fost","year":"2008","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0110","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0125","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ajh.21492","article-title":"Treatment of multiple myeloma in patients with Gaucher disease","volume":"84","author":"Machaczka","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","article-title":"Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism","volume":"18","author":"Mistry","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.achaem.2014.01.004","article-title":"Long-lasting pancytopenia after chemotherapy as a disclosing symptom of Gaucher disease in a patient with lung cancer","volume":"45","author":"Markuszewska-Kuczy\u0144ska","year":"2014","journal-title":"Acta Haematol. Pol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0140","first-page":"205","article-title":"Cytokines in Gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0145","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2005.03.006","article-title":"TNF-\u03b1 levels and TNF-\u03b1 gene polymorphism in type I Gaucher disease","volume":"31","author":"Altarescu","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0170","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1056\/NEJM199909023411002","article-title":"A population-based study on the clinical expression of the hemochromatosis gene","volume":"341","author":"Olynyk","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0175","first-page":"652","article-title":"Validation of a competitive ELISA assay for the quantification of human serum hepcidin","volume":"75","author":"Dahlfors","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(89)90536-9","article-title":"Prediction of severity of Gaucher's disease by identification of mutations at DNA level","volume":"8659","author":"Zimran","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009734.2013.857373","article-title":"Recurrent pulmonary aspergillosis and mycobacterial infection in an unsplenectomized patient with type 1 Gaucher disease","volume":"119","author":"Machaczka","year":"2014","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0195","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21721","article-title":"Hyperferritinemia and irol overload in type 1 Gaucher disease","volume":"85","author":"Stein","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0200","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2009.140053","article-title":"Hepcidin in human iron disorders: diagnostic implications","volume":"57","author":"Kroot","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0205","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.20908","article-title":"Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention","volume":"82","author":"Mistry","year":"2007","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/1678-4685-GMB-2015-0125","article-title":"The prognostic value of the serum ferritin in a southern Brazilian cohort of patients with Gaucher disease","volume":"39","author":"Koppe","year":"2016","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0215","first-page":"388","article-title":"Gaucher's disease: a disease with chronic stimulation of the immune system","volume":"106","author":"Shoenfeld","year":"1982","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0225","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0230","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1073\/pnas.73.3.857","article-title":"Novel mechanism for translational control in regulation of ferritin synthesis by iron","volume":"73","author":"Zahringer","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0235","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/carcin\/bgl210","article-title":"Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts","volume":"28","author":"Chen","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010163","article-title":"Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert","volume":"5","author":"Maffettone","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0245","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","article-title":"Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation","volume":"102","author":"Ganz","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0250","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1210\/jc.2007-1702","article-title":"Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance","volume":"93","author":"Langeveld","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0255","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/CS20090399","article-title":"Insulin resistance and hyperinsulinaemia in the development and progression of cancer","volume":"118","author":"Godsland","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0260","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbagen.2011.07.016","article-title":"The transferrin receptor and the targeted delivery of therapeutic agents against cancer","volume":"1820","author":"Daniels","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0265","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1084\/jem.20042433","article-title":"TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis","volume":"202","author":"Chen","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0270","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.4049\/jimmunol.177.8.4966","article-title":"Cutting edge: inhibition of T cell activation by TIM-2","volume":"177","author":"Knickelbein","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.20050308","article-title":"Tim-2 regulates T helper type 2 responses and autoimmunity","volume":"202","author":"Chakravarti","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.devcel.2008.12.002","article-title":"Scara5 is a ferritin receptor mediating non-transferrin iron delivery","volume":"16","author":"Li","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0285","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ajh.2830180407","article-title":"Interaction between a serum factor and T lymphocytes in Gaucher disease","volume":"18","author":"Bassan","year":"1985","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0290","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/bcmd.1999.0237","article-title":"T cell numbers relate to bone involvement in Gaucher disease","volume":"25","author":"Lacerda","year":"1999","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0295","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V78.4.1056.1056","article-title":"Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control","volume":"78","author":"Fargion","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.10.010_bb0300","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1538-7836.2005.01218.x","article-title":"Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off","volume":"3","author":"Guo","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0305","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.0812010106","article-title":"Regulatory effects of ferritin on angiogenesis","volume":"106","author":"Coffman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2016.10.010_bb0310","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3324\/haematol.2013.092460","article-title":"Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27years follow-up","volume":"99","author":"Kristinsson","year":"2014","journal-title":"Haematologica"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616302066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616302066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:30Z","timestamp":1761050010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979616302066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":62,"alternative-id":["S1079979616302066"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.010","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}